Trending News EU – 16 March 2023

The Chief Marketing Officer of a prescription digital therapeutics (PDT) company was seeking to prepare the organization for future launches. Read how Vynamic leveraged both Healthcare Technology and Life Sciences expertise to build a detailed, practical launch playbook used to expand commercialization in both products and patient types.

Following the acquisition of a large company, Vynamic’s global biopharmaceutical client needed to integrate the people, processes, and technology from both organizations into a new, unified Commercial Operations group. Read how Vynamic provided the collaborative leadership and deep expertise to successfully combine the organizations through enhanced ways of working and common technologies.

Following an acquisition, a global biopharmaceutical company needed to consolidate disparate brands into a single portfolio and enable a new brands director. Read how Vynamic completed a comprehensive assessment and knowledge transfer to enable the new director to lead the portfolio and implement recommended improvements.

In the midst of integrating one company from a prior deal, a mid-sized pharmaceutical organization made an additional acquisition with a narrow timeframe to complete the integration to meet contractual obligations. Read how Vynamic adapted plans and led a range of activities to meet the original target integration dates despite significant client resource constraints.

Read how a European-based regional HR organization within a Global Pharmaceutical company asked Vynamic to assess the current state of Diversity, Equity, & Inclusion (DEI) across their local countries with the goal of developing a recommended DEI operating model, strategy, and implementation plan.

While awaiting approval to launch a new product, a large pharmaceutical company identified a need to revisit their market access strategy due to various evolving external factors that could require adjustments in their launch approach. Read how Vynamic helped this client assess those factors, refresh their strategy, identify/implement recommended adjustments, and implement an ongoing performance monitoring framework that ensured they would remain nimble with the evolving market.